Literature DB >> 19678528

Steep dose gradients for simultaneous integrated boost IMRT.

Klaus Bratengeier1, Jürgen Meyer, Franz Schwab, Dirk Vordermark, Michael Flentje.   

Abstract

Steep dose gradients between two planning target volumes (PTVs) as may be required for simultaneous integrated boosts (SIB) should be an option provided by IMRT algorithms. The aim was to analyse the geometry of the SIB problem and to implement the results in an algorithm for IMRT segment generation denoted two-step intensity modulated radiotherapy (2-Step IMRT). It was hypothesized that a gap between segments directed to the inner and the outer PTV would steepen the dose gradient. The mathematical relationships were derived from the individual dose levels and the geometry (diameters) of the PTVs. The results generated by means of 2-Step IMRT segments were equivalent or better than the segment generation using a commercial IMRT planning system. The dose to both the inner and the outer PTV was clearly more homogeneous and the composite objective value was the lowest. The segment numbers were lower or equal--with better sparing of the surrounding tissue. In summary, it was demonstrated that 2-Step IMRT was able to achieve steep dose gradients for SIB constellations.

Entities:  

Mesh:

Year:  2009        PMID: 19678528     DOI: 10.1016/j.zemedi.2008.07.004

Source DB:  PubMed          Journal:  Z Med Phys        ISSN: 0939-3889            Impact factor:   4.820


  3 in total

1.  Pre-segmented 2-Step IMRT with subsequent direct machine parameter optimisation - a planning study.

Authors:  Klaus Bratengeier; Jürgen Meyer; Michael Flentje
Journal:  Radiat Oncol       Date:  2008-11-06       Impact factor: 3.481

2.  Two-step intensity modulated arc therapy (2-step IMAT) with segment weight and width optimization.

Authors:  Jidi Sun; Theam Yong Chew; Juergen Meyer
Journal:  Radiat Oncol       Date:  2011-06-02       Impact factor: 3.481

3.  Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose-escalation feasibility study.

Authors:  Savino Cilla; Francesco Deodato; Anna Ianiro; Gabriella Macchia; Vincenzo Picardi; Milly Buwenge; Silvia Cammelli; Alice Zamagni; Vincenzo Valentini; Alessio G Morganti
Journal:  J Appl Clin Med Phys       Date:  2018-09-15       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.